The two offices carry the addresses of 6611 Tributary St. and 6411 Beckley St., and were developed in 1989 and 1999, respectively. Together, the properties have a total current assessed value of approximately $11.6 million.
The deal leaves Guilford with net proceeds of $19.4 million, which the company plans to use for general corporate purposes. As for BioMed, the purchase holds a great deal of significance. "This transaction represents the company's entry into the Maryland market, the fifth largest life science market in the US," BioMed vice president of acquisitions Matthew G. McDevitt notes.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to asset-and-logo-licensing@alm.com. For more inforrmation visit Asset & Logo Licensing.
